Abstract
Previous studies in our laboratories demonstrated that overexpression of manganese superoxide dismutase (MnSOD) suppressed both the incidence and multiplicity of papillomas in a DMBA/TPA multi-stage skin carcinogenesis model. The activity of activator protein-1 (AP-1), which is associated with tumor promotion, was reduced in MnSOD transgenic mice overexpressing MnSOD in the skin, suggesting that MnSOD may reduce tumor incidence by suppressing AP-1 activation. In the present study, we report that reduction of MnSOD by heterozygous knockout of the MnSOD gene (Sod2 −/+, MnSOD KO) increased the levels of oxidative damage proteins and the activity of AP-1 following TPA treatment. RNA levels of ornithine decarboxylase (ODC) were also increased, suggesting an increase in cell proliferation in the KO mice. Histological examination confirmed that the number of proliferating cells in DMBA/TPA-treated mouse skin were higher in the KO mice. Interestingly, histological examination also demonstrated greater numbers of apoptotic cells in the KO mice after DMBA/TPA treatment. Evidence of apoptosis, including DNA fragmentation, cytochrome c release from mitochondria, and caspase 3 activation were also observed by biochemical assays of the skin tissues. Apoptosis was associated with an increase in nuclear levels of p53 as determined by Western analysis. Quantitative immunogold ultrastructural analysis confirmed that p53 immunoreactive protein levels were increased to a greater level in the nuclei of epidermal cells from MnSOD KO mice compared to epidermal nuclei from wild type mice similarly treated. Moreover, p53 levels further increased in the mitochondria of DMBA/TPA treated mice, and this increase was much greater in the MnSOD KO than in the wild type mice, suggesting a link between MnSOD deficiency and mitochondrial-mediated apoptosis. Pathological examination reveals no difference in the incidence and frequency of papillomas comparing the KO mice and their wild type littermates. Taken together, these results suggest that: (1) MnSOD deficiency enhanced TPA-induced oxidative stress and AP-1 and p53 levels, consistent with the increase in both proliferation and apoptosis events in the MnSOD KO mice, and (2) increased apoptosis may negate increased proliferation in the MnSOD deficient mice during an early stage of tumor development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- The abbreviations used are: 4-HNE:
-
4-hydroxy-2-nonenal
- AP-1:
-
activator protein-1
- DMBA:
-
7,12-dimethylbenz(α)-anthracene
- DMSO:
-
dimethylsulfoxide
- DTT:
-
dithiothreitol
- MnSOD:
-
manganese superoxide dismutase
- EMSA:
-
electrophoresis mobility shift assay
- JNK:
-
c-Jun terminal kinase
- ODC:
-
ornithine decarboxylase
- PBS:
-
phosphate-buffered saline
- PKC:
-
protein kinase C
- PMSF:
-
phenylmethylfulfonyl fluoride
- ROS:
-
reactive oxygen species
- RT–PCR:
-
reverse transcription-PCR
- TBS:
-
Tris-buffered saline
- TPA:
-
12-O-tetradecanoylphorbol-13-acetate
References
Agarwal R, Khan SG, Athar M, Zaidi SIA, Bickers DR, Mukhtar H . 1993 Mol. Carcinog. 8: 290–298
Amstad PA, Liu H, Ichimiya M, Berezesky IK, Trump BF . 1997 Carcinogenesis 18: 479–484
Bowden GT, Finch J, Domann F, Krieg P . 1995 Molecular mechanisms involved in skin tumor initiation, promotion and progression Mukhtar H (ed) Skin cancer: mechanisms and human relevance Boca Raton, FL: CRC Press, Inc pp 99–111
Bernstein LR, Ben-Ari ET, Simek SL, Colburn NH . 1991 Environ. Health Perspect. 93: 111–119
Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM . 1993 Proc. Natl. Acad. Sci. USA 90: 3113–3117
Das KC, Guo XL, White CW . 1998 J. Biol. Chem. 273: 34639–34645
Donahue RJ, Razmara M, Hoek JB, Knodsen TB . 2001 FASEB J. 15: 635–644
Drane P, Bravard A, Bouvard V, May E . 2001 Oncogene 20: 430–439
Du C, Fang M, Li Y, Li L, Wang X . 2000 Cell 102: 33–42
Epperly MW, Sikora C, Defilippi S, Bray J, Koe G, Liggitt D, Luketich JD, Greenberger JS . 2000 Int. J. Cancer 90: 128–137
Fischer SM, Jasheway DW, Klann RC, Butler AP, Patrick KE, Baldwin JK, Cameron GS . 1989 Cancer Res. 49: 6693–6699
Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR . 2000 Nat. Cell Biol. 2: 156–162
Gonzalez-Zulueta M, Ensz LM, Mukhina G, Lebovitz RM, Zwacka RM, Engelhardt JF, Oberley LW, Dawson VL, Dawson TM . 1998 J. Neurosci. 18: 2040–2055
Gopalakrishna R, Anderson WB . 1989 Proc. Natl. Acad. Sci. USA 86: 6758–6762
Guidot DM, Rapine JE, Kitlowski AD, Flores SC, Nelson SK, Wright RM, McCord JM . 1995 J. Clin. Invest. 96: 1131–1136
Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB . 1998 J. Clin. Invest. 101: 1811–1820
Karin M . 1995 J. Biol. Chem. 270: 16483–16486
Keller JN, Kindy M, Holtsberg FW, St. Clair DK, Yen H-C, Mattson MP . 1998 J. Neurosci. 18: 687–697
Khajuria A, Thusu N, Zutshi U, Bedi KL . 1998 Mol. Cell. Biochem. 189: 113–118
Kinscherf R, Claus R, Wagner M, Gehrke C, Kamencic H, Hou D, Nauen O, Schmiedt W, Kovacs G, Pill J, Metz J, Deigner H-P . 1998 FASEB J. 12: 461–467
Kiningham KK, Oberley TD, Lin S, Mattingly CA, St. Clair DK . 1999 FASEB J. 13: 1601–1610
Lam EW, Zwacka R, Engelhardt JF, Davidson BL, Domann FE, Yan T, Oberley LW . 1997 Cancer Res. 57: 5550–5556
Lam EW, Zwacka R, Seftor EA, Nieva DR, Davidson BL, Engelhardt JF, Hendrix MJ, Oberley LW . 1999 Free Radic. Biol. Med. 27: 572–579
Li JJ, Oberley LW, St. Clair DK, Ridnour LA, Oberley TD . 1995 Oncogene 10: 1989–2000
Li N, Oberley TD, Oberley LW, Zhong W . 1998 Prostate 35: 221–233
Li P-F, Dietz R, von Harsdorf Rudiger . 1999 EMBO J. 18: 6027–6036
Liu R, Oberley TD, Oberley LW . 1997 Hum. Gene Ther. 8: 585–595
Majima HJ, Oberley TD, Furakawa K, Mattson MP, Yen HC, Szweda LI, St. Clair DK . 1998 J. Biol. Chem. 273: 8217–8224
Marchenko ND, Zaika AI, Moll UM . 2000 J. Biol. Chem. 275: 16202–16212
McGarrity TJ, Peiffer LP, Granville DJ, Carthy CM, Levy JG, Khandelwal M, Hunt DW . 2001 Cancer Lett. 163: 33–41
McSwine-Kennick RL, McKeegan EM, Johnson MD, Morin MJ . 1991 J. Biol. Chem. 266: 15135–15143
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Moll UM, Zaika A . 2001 FEBS Lett. 493: 65–69
Nakamura Y, Kamamoto N, Ohto Y, Torikai K, Murakami A, Ohigashi H . 1999 Cancer Lett. 140: 37–45
Nishizuka Y . 1988 Nature 334: 661–665
Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000 Cell 102: 849–862
Pence B, Reiners JJ . 1987 Cancer Res. 47: 6388–6392
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . 1997 Nature 389: 300–305
Porter AG . 1999 Trends Cell. Biol. 10: 394–401
Reiners JJ, Pence BC, Barcus MCS, Cantu A . 1987 Cancer Res. 47: 1775–1779
Reiners JJ, Thai G, Rupp T, Cantu AR . 1991 Carcinogenesis 12: 2337–2343
Remmen HV, Salvador C, Yang H, Huang TT, Epstein CJ, Richardson A . 1999 Arch. Biochem. Biophys. 363: 91–97
Ruggeri BA, Klein-Szanto AJP . 1995 Alterations in the p53 and Rb-1 tumor suppression genes in carcinogen-induced murine skin models of squamous cell neoplasias. Mukhtar H (ed) Skin Cancer: mechanisms and human relevance Boca Raton, FL: CRC Press, Inc pp 339–347
Safford SE, Oberley TD, Urano M, St. Clair DK . 1994 Cancer Res. 54: 4261–4265
Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW . 1999 Science 284: 156–159
Spitz DR, Oberley LW . 1989 Anal. Biochem. 179: 8–18
St. Clair DK, Oberley TD, Ho YS . 1991 FEBS Lett. 293: 199–202
Stadtman ER . 1992 Science 257: 1220–1224
Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G . 1999 Nature 397: 441–446
Tokino T, Nakamura Y . 2000 Crit. Rev. Oncol. Hematol. 33: 1–6
Urano M, Kuroda M, Reynolds R, Oberley TD, St. Clair DK . 1995 Cancer Res. 55: 2490–2493
Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL . 2000 Cell 102: 43–53
Verma AJ, Pong RC, Erickson D . 1986 Cancer Res. 46: 6149–6155
Weisiger RA, Fridovich I . 1973 J. Biol. Chem. 248: 4793–4796
Wong GHW, Elwell JH, Oberley LW, Goeddel D . 1989 Cell 58: 923–931
Xu Y, Krishnan A, Wan XS, Majima H, Yeh CC, Ludewig G, Kasarskis EJ, St. Clair DK . 1999 Oncogene 18: 93–102
Yan T, Oberley LW, Zhong W, St. Clair DK . 1996 Cancer Res. 56: 2864–2871
Young MR, Li JJ, Rincon M, Flavell RA, Sathyanarayana BK, Hunziker R, Colburn N . 1999 Proc. Natl. Acad. Sci. USA 96: 9827–9832
Zhao Y, Kiningham KK, Lin S, St. Clair DK . 2001a Antioxidant and Redox Signaling 3: 375–386
Zhao Y, Xue Y, Oberley TD, Kiningham KK, Lin SM, Yen HC, Majima H, Hines J, St. Clair DK . 2001b Cancer Res. 61: 6082–6088
Zhong W, Oberley LW, Oberley TD, St. Clair DK . 1997 Oncogene 14: 481–490
Acknowledgements
The authors wish to thank Dr Judy Hines, Cathleen Hsu and Marcie Cole for their technical assistance. This work was supported by NIH grants CA 73599, CA 73599-S1, and AG-08938. Luksana Chaiswing is partially supported by the Thailand Research Fund under the Golden Jubilee Program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, Y., Oberley, T., Chaiswing, L. et al. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene 21, 3836–3846 (2002). https://doi.org/10.1038/sj.onc.1205477
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205477
Keywords
This article is cited by
-
Ileal proteomic changes associated with IL-25-mediated resistance against intestinal trematode infections
Parasites & Vectors (2020)
-
Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis
Oncogene (2016)
-
Differential alterations in the small intestine epithelial cell turnover during acute and chronic infection with Echinostoma caproni (Trematoda)
Parasites & Vectors (2015)
-
Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polγ against UV-induced inactivation
Oncogene (2012)
-
Manganese superoxide dismutase: beyond life and death
Amino Acids (2012)